MDLinx Blog - Medical News and more.

ASA reduces risk of cancer

Mar 21, 2012 9:22:00 PM / by D. Scott Cunningham, MD, PhD

A meta-analysis published in The Lancet Oncology has confirmed that long-term aspirin use reduces the risk of cancer.  Specifically, the risk of colorectal (OR=0.62), esophageal, gastric, biliary, and breast cancer was reduced in patients who used ASA long-term.  Moreover, the risk of distant metastases (OR=0.69), but not regiona spread, was reduced. 

Tags: Oncology

Keep up to date on the latest medical news at MDLinx - FREE!

  • Stay current on the latest medical literature, research and clinical news
  • MD jobs and physician job search at our new medical job Career Center
  • Receive invitations to paid market research
  • Search Clinical Trials and Medical Conferences

Follow Us